New publication in ACS Omega
Our work on biotinylated diaryl isoxazole derivatives with enhanced JAK1 inhibitory, antiproliferative and apoptotic activity is out in ACS Omega.
News
News
Announcements, new papers and funded projects.
Three projects funded under the TÜSEB 2026 A and B Group calls
Three projects from the group have been accepted for funding under the TÜSEB 2026 A and B Group calls.
Student recruitment
Recruitment runs on a periodic basis; applications usually open in June and again in November.
Funding
Research grants
Projects supported by TÜBİTAK, TÜSEB and other funders.
TÜBİTAK 1001 — 126Z329
Sarmal Bölge PIK3CA Mutant Meme Kanserinde Etkileşim Ağlarına Dayalı Fonksiyonel Bağımlılıkların PIK3alpha İnhibitörü Yanıtı ile İlişkisinin İncelenmesi
July 29, 2026
TÜSEB — 52438 – 2026-B1-01
Türkiye Popülasyonuna Özgü Sistinozis Genotiplerinde Ferroptotik Duyarlılığın Fonksiyonel ve Çoklu-Omik Analizlerle Araştırılması
June 5, 2026
TÜSEB — 52232
Nerve-tumor Crosstalk and Novel Combination Therapy Strategies in PIK3CA-H1047R Mutant Breast Cancer
June 5, 2026
TÜSEB — 56027
Combinatorial Targeting of PI3K and Sphingomyelin Metabolism in Castration-Resistant Prostate Cancer
June 5, 2026
TÜBİTAK 1001 — 125Z409
Identification and Targeting of Ferroptosis-Regulating Genes Involved in Resistance to Alpelisib–Fulvestrant–Mediated Growth Suppression in PIK3CA-Mutant Breast Cancers
November 5, 2025
TÜBİTAK 1002 — 125Z193
Analysis of Intracellular Localization, Protein Interactions, and Stability of TBC1D31 and the p.Gln63Glu Variant
June 3, 2025
TÜBİTAK 1001 — 123Z457
Identification and Targeting of Enzymes Regulating Sphingolipid Metabolism via PI3K Signaling in Prostate Cancer
November 15, 2023